rintodestrant (G1T48)

News alerts, weekly reports and conference planners

Company:

University of Illinois

Drug class:

Selective estrogen receptor degrader

Related drugs:

ER positive	HER2 Negative Breast Cancer	ER positive	HER2 Negative Breast Cancer	G1T48 Sensitive: C3 – Early Trials G1T48 Sensitive : C3	G1T48 Sensitive: C3 – Early Trials G1T48 Sensitive : C3
ER mutation	HER2 Negative Breast Cancer	ER mutation	HER2 Negative Breast Cancer	G1T48 Sensitive: C4 – Case Studies G1T48 Sensitive : C4	G1T48 Sensitive: C4 – Case Studies G1T48 Sensitive : C4

Associations
(2)